19P * High reduction of circulating tumor cells (CTCs) in...

Annals of Oncology 2015 / 05 Vol. 26; Iss. suppl 3

19P * High reduction of circulating tumor cells (CTCs) in patients with HER2-negative recurrent or metastatic breast cancer treated with eribulin as third-line therapy: ONSITE trial (OncoSur Analysis of the Treatment in Third Line of ABC with Eribulin)

Manso, L., Moreno, F., Delgado, J. I., Echarri, M. J., Lopez, A., Izarzugaza, Y., Borrega, P., Martinez, N., Olier, C., Cortes-Funes, H.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
26
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv115.07
Date:
May, 2015
File:
PDF, 32 KB
2015
Conversion to is in progress
Conversion to is failed